IN2009KN04355A - - Google Patents
Download PDFInfo
- Publication number
- IN2009KN04355A IN2009KN04355A IN4355KON2009A IN2009KN04355A IN 2009KN04355 A IN2009KN04355 A IN 2009KN04355A IN 4355KON2009 A IN4355KON2009 A IN 4355KON2009A IN 2009KN04355 A IN2009KN04355 A IN 2009KN04355A
- Authority
- IN
- India
- Prior art keywords
- promoter
- poll
- useful
- rna polymerase
- rna
- Prior art date
Links
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 abstract 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 abstract 1
- 102000017143 RNA Polymerase I Human genes 0.000 abstract 1
- 108010013845 RNA Polymerase I Proteins 0.000 abstract 1
- 108020000999 Viral RNA Proteins 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000008488 polyadenylation Effects 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94665107P | 2007-06-27 | 2007-06-27 | |
| EP07450177A EP2045323A1 (en) | 2007-10-05 | 2007-10-05 | Linear expression constructs for production of influenza virus particles |
| PCT/EP2008/058182 WO2009000891A2 (en) | 2007-06-27 | 2008-06-26 | Linear expression constructs for production of influenza virus particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2009KN04355A true IN2009KN04355A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-07-10 |
Family
ID=39099653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4355KON2009 IN2009KN04355A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2007-06-27 | 2008-06-26 |
Country Status (9)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9091510B2 (en) | 2007-03-21 | 2015-07-28 | Schott Corporation | Transparent armor system and method of manufacture |
| EP2072058A1 (en) | 2007-12-21 | 2009-06-24 | Avir Green Hills Biotechnology Research Development Trade Ag | Modified influenza virus |
| EP2233568A1 (en) | 2009-03-19 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade AG | Novel method for generation of RNA virus |
| DK2401384T3 (da) | 2009-05-21 | 2013-01-14 | Novartis Ag | Revers genetik under anvendelse af ikke-endogene pol-I-promotorer |
| WO2011012999A1 (en) * | 2009-07-31 | 2011-02-03 | Novartis Ag | Reverse genetics systems |
| EP2491117B2 (en) | 2009-10-20 | 2017-06-28 | Novartis AG | Improved reverse genetics methods for virus rescue |
| WO2011151470A2 (en) | 2010-06-02 | 2011-12-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Novel method for generation of rna virus |
| CN102495208B (zh) * | 2011-10-24 | 2014-03-26 | 山东省农业科学院畜牧兽医研究所 | 禽流感病毒rt-pcr elisa试剂盒 |
| CN104168912B (zh) * | 2011-11-10 | 2016-08-24 | 北京艾棣维欣生物技术有限公司 | 促进剂-dna组合疫苗 |
| JP6054883B2 (ja) | 2012-03-02 | 2016-12-27 | ノバルティス アーゲー | インフルエンザウイルスの再集合 |
| MX2015006927A (es) | 2012-12-03 | 2016-02-05 | Novartis Ag | Redistribucion de virus de la influenza. |
| JP6525469B2 (ja) | 2013-03-13 | 2019-06-05 | ノバルティス アーゲー | インフルエンザｂ型ウイルス再集合 |
| DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
| DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
| KR20160014657A (ko) | 2013-06-06 | 2016-02-11 | 노파르티스 아게 | 인플루엔자 바이러스 재배열 |
| US11013795B2 (en) | 2015-06-26 | 2021-05-25 | Seqirus UK Limited | Antigenically matched influenza vaccines |
| CA2990745A1 (en) | 2015-07-07 | 2017-01-12 | Seqirus UK Limited | Influenza potency assays |
| EP4061930A1 (en) | 2019-11-18 | 2022-09-28 | Seqirus Pty Ltd | Method for producing reassortant influenza viruses |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999064068A1 (en) * | 1998-06-12 | 1999-12-16 | Mount Sinai School Of Medicine Of The City University Of New York | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| CA2334857C (en) * | 1998-06-12 | 2012-03-20 | Mount Sinai School Of Medicine Of The City University Of New York | Interferon inducing genetically engineered attenuated viruses |
| US6280977B1 (en) * | 1999-03-24 | 2001-08-28 | Gene Therapy Systems | Method for generating transcriptionally active DNA fragments |
| EP1185615B1 (en) * | 1999-04-06 | 2007-08-01 | Wisconsin Alumni Research Foundation | Recombinant influenza viruses for vaccines and gene therapy |
| AU5998400A (en) * | 1999-07-14 | 2001-01-30 | Mount Sinai School Of Medicine Of The City University Of New York, The | In vitro reconstitution of segmented negative-strand rna viruses |
| EP2085468A1 (en) * | 2000-04-28 | 2009-08-05 | St. Jude Children's Research Hospital | DNA transfection system for the generation of infectious influenza virus |
| US8012736B2 (en) * | 2002-04-26 | 2011-09-06 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| DE602004027537D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2003-12-23 | 2010-07-15 | Medimmune Inc | |
| EP1773384B1 (en) * | 2004-06-01 | 2015-08-12 | Icahn School of Medicine at Mount Sinai | Genetically engineered swine influenza virus and uses thereof |
| WO2007044024A2 (en) | 2004-11-19 | 2007-04-19 | Wisconsin Alumni Research Foundation | Recombinant influenza vectors with tandem transcription units |
| US8043856B2 (en) * | 2007-06-14 | 2011-10-25 | Wisconsin Alumni Research Foundation | Adenoviral vectors for influenza virus production |
-
2007
- 2007-10-05 EP EP07450177A patent/EP2045323A1/en not_active Withdrawn
-
2008
- 2008-06-26 US US12/666,459 patent/US20100129399A1/en not_active Abandoned
- 2008-06-26 CN CN2008800223549A patent/CN101952427A/zh active Pending
- 2008-06-26 EA EA201000076A patent/EA017456B1/ru not_active IP Right Cessation
- 2008-06-26 IN IN4355KON2009 patent/IN2009KN04355A/en unknown
- 2008-06-26 CA CA2689569A patent/CA2689569C/en active Active
- 2008-06-26 EP EP08774359.7A patent/EP2160462B1/en active Active
- 2008-06-26 NZ NZ582102A patent/NZ582102A/en not_active IP Right Cessation
- 2008-06-26 AU AU2008267180A patent/AU2008267180B2/en active Active
- 2008-06-26 WO PCT/EP2008/058182 patent/WO2009000891A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009000891A3 (en) | 2009-02-26 |
| CA2689569A1 (en) | 2008-12-31 |
| CN101952427A (zh) | 2011-01-19 |
| US20100129399A1 (en) | 2010-05-27 |
| EP2160462B1 (en) | 2017-07-26 |
| EA201000076A1 (ru) | 2010-06-30 |
| AU2008267180B2 (en) | 2014-07-10 |
| WO2009000891A2 (en) | 2008-12-31 |
| EP2045323A1 (en) | 2009-04-08 |
| CA2689569C (en) | 2020-10-27 |
| EA017456B1 (ru) | 2012-12-28 |
| EP2160462A2 (en) | 2010-03-10 |
| NZ582102A (en) | 2012-06-29 |
| AU2008267180A1 (en) | 2008-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2009KN04355A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| EA200501890A1 (ru) | Вирусы гриппа высокого титра для приготовления вакцин и генной терапии | |
| WO2022221335A8 (en) | Respiratory virus combination vaccines | |
| EP4385567A3 (en) | Methods and compositions for rna-guided treatment of hiv infection | |
| MXPA06013411A (es) | Procedimiento para la produccion de una vacuna contra la influenza. | |
| TR201815882T4 (tr) | Tal efektörü aracılı dna modifikasyonu. | |
| MX2018008135A (es) | Moleculas de acido nucleico de influenza y vacunas elaboradas a partir de las mismas. | |
| NZ606087A (en) | Influenza vaccine | |
| WO2007053696A3 (en) | Rnai inhibition of influenza virus replication | |
| EA200970013A1 (ru) | Вакцинация против гриппа по схеме многократного введения с использованием безадъювантной дозы | |
| AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
| WO2009080806A3 (en) | Modified influenza virus | |
| PH12013502442A1 (en) | Inactivated dengue virus vaccine | |
| UA108902C2 (uk) | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
| EP4126032A4 (en) | UNIVERSAL INFLUENZA VACCINE USING NUCLEOSIDE-MODIFIED MRNA | |
| HRP20090230T1 (hr) | Replikacijski-defektni rna virusi kao cjepiva | |
| WO2002087494A3 (en) | Novel vaccine | |
| GEP20115293B (en) | Isolated extract of walnuts, process for its obtaining and its use | |
| NZ597601A (en) | Treatment and prevention of influenza | |
| AU2024235086A1 (en) | Nucleic acid influenza vaccines and respiratory virus combination vaccines | |
| AU2016204276A1 (en) | Methods for producing virus particles with simplified glycosylation of surface proteins | |
| EA201100902A1 (ru) | Новый способ получения рнк-вируса | |
| UA114603C2 (uk) | Конструкція для сайленсингу гена p0 та її застосування | |
| NZ580603A (en) | Intradermal influenza vaccine | |
| WO2007092315A3 (en) | Immunostimulation by cpg oligonucleotide-virus complexes |